ISENTRESS
Generic: RALTEGRAVIR
Merck Sharp & Dohme LLCManufacturer
ORALRoute
RALTEGRAVIR POTASSIUMActive Substance
2011-12-21Original Approval
ISENTRESS is FDA application NDA203045, sponsored by MSD SUB MERCK. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INTERACTION
1,216 reports
2
FOETAL EXPOSURE DURING PREGNANCY
1,100 reports
3
DEPRESSION
1,018 reports
4
ANXIETY
965 reports
5
PAIN
917 reports
6
EMOTIONAL DISTRESS
789 reports
7
MATERNAL EXPOSURE DURING PREGNANCY
750 reports
8
EXPOSURE DURING PREGNANCY
744 reports
9
ANHEDONIA
708 reports
10
VIROLOGIC FAILURE
587 reports